At-Large Director (Position 10)

Suzanne Thibodeaux, MD, PhD, CABP(H)

Washington University School of Medicine

Suzanne Thibodeaux, MD, PhD, CABP(H), is an associate professor of pathology and immunology and Co-Section Head of Transfusion Medicine/Blood Bank/HLA at Washington University School of Medicine. She serves as medical and laboratory director of the Cellular Therapy Laboratory, medical director of apheresis, and associate medical director of transfusion and blood banking medicine at Barnes-Jewish Hospital in Saint Louis. She also serves as the Program Director for Blood Banking and Transfusion Medicine Fellowship.

Thibodeaux received a bachelor of science degree in cellular and molecular biology from Tulane University. She then earned her doctor of philosophy degree and doctor of medicine degree from the University of Texas Health Science Center in San Antonio. Thibodeaux completed residency in clinical pathology in 2016, during which time she served as chief resident, followed by a fellowship in blood banking and transfusion medicine, both at the Hospital of the University of Pennsylvania.

After completing training, Thibodeaux joined the faculty in the Department of Pathology and Immunology at Washington University School of Medicine in St. Louis.

Thibodeaux is actively involved in multidisciplinary and collaborative approaches to patient care, education, and clinical and translational research as it relates to cellular therapy and transfusion medicine, demonstrated by her multiple publications, presentations and scholarly pursuits in these areas.

Thibodeaux has been an active member of AABB since joining as a trainee. She served on the Cellular Therapy Education Committee and contributed to AABB’s Flow Cytometry Educational Module and the Certified Advanced Biotherapies Professional (CABP) examination. She has contributed to the 10th edition of the AABB Standards for Cellular Therapies and is currently contributing to the 11th edition. As an elected member of the Cellular Therapy Section Coordinating Committee, she helps to lead the Quality, Regulatory and Management (QRM) subsection. She aligns her efforts in AABB and other organizations with her personal and professional goals of helping to advance cellular therapies, transfusion medicine and education, particularly where clinical, research and regulatory aspects of the field meets.